James I. Fells

1.1k total citations
27 papers, 848 citations indexed

About

James I. Fells is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, James I. Fells has authored 27 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in James I. Fells's work include Sphingolipid Metabolism and Signaling (13 papers), Receptor Mechanisms and Signaling (7 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). James I. Fells is often cited by papers focused on Sphingolipid Metabolism and Signaling (13 papers), Receptor Mechanisms and Signaling (7 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). James I. Fells collaborates with scholars based in United States, Hungary and China. James I. Fells's co-authors include Abby L. Parrill, Gábor Tigyi, Jianxiong Liu, Donna Perygin, Ryoko Tsukahara, Yuko Fujiwara, Gábor Tigyi, Yuko Fujiwara, Duane D. Miller and Renukadevi Patil and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

James I. Fells

27 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James I. Fells United States 18 717 201 81 64 62 27 848
Shi-Hao Tan Singapore 8 468 0.7× 150 0.7× 89 1.1× 94 1.5× 121 2.0× 9 945
Charles A. Berdan United States 11 436 0.6× 144 0.7× 129 1.6× 59 0.9× 88 1.4× 12 742
Rachel Kama Israel 12 676 0.9× 320 1.6× 98 1.2× 93 1.5× 64 1.0× 13 911
Pasquale Zizza Italy 22 847 1.2× 104 0.5× 132 1.6× 99 1.5× 41 0.7× 44 1.1k
Henning Gram Hansen Denmark 15 721 1.0× 273 1.4× 33 0.4× 56 0.9× 35 0.6× 19 935
Beth A. Strifler United States 10 655 0.9× 114 0.6× 85 1.0× 54 0.8× 27 0.4× 10 895
Junya Hasegawa Japan 21 526 0.7× 464 2.3× 125 1.5× 36 0.6× 124 2.0× 37 1.1k
Taichi Kumanomidou Japan 6 456 0.6× 237 1.2× 50 0.6× 64 1.0× 78 1.3× 7 848
Pornpun Aramsangtienchai United States 11 599 0.8× 103 0.5× 57 0.7× 196 3.1× 97 1.6× 12 914
Haixia Zou China 9 382 0.5× 146 0.7× 43 0.5× 43 0.7× 109 1.8× 11 782

Countries citing papers authored by James I. Fells

Since Specialization
Citations

This map shows the geographic impact of James I. Fells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James I. Fells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James I. Fells more than expected).

Fields of papers citing papers by James I. Fells

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James I. Fells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James I. Fells. The network helps show where James I. Fells may publish in the future.

Co-authorship network of co-authors of James I. Fells

This figure shows the co-authorship network connecting the top 25 collaborators of James I. Fells. A scholar is included among the top collaborators of James I. Fells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James I. Fells. James I. Fells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Wensheng, James I. Fells, Dane J. Clausen, et al.. (2021). Discovery of macrocyclic HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation. Bioorganic & Medicinal Chemistry Letters. 47. 128168–128168. 7 indexed citations
2.
Yu, Wensheng, Jian Liu, Younong Yu, et al.. (2020). Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation. Bioorganic & Medicinal Chemistry Letters. 30(13). 127197–127197. 22 indexed citations
3.
Fells, James I., Xi Ai, Adam B. Weinglass, et al.. (2020). Identification of free fatty acid receptor 2 agonists using virtual screening. Bioorganic & Medicinal Chemistry Letters. 30(21). 127460–127460. 2 indexed citations
4.
Clausen, Dane J., Jian Liu, Wensheng Yu, et al.. (2020). Development of a selective HDAC inhibitor aimed at reactivating the HIV latent reservoir. Bioorganic & Medicinal Chemistry Letters. 30(17). 127367–127367. 18 indexed citations
5.
Hu, Yuan, Deping Wang, Hongwu Wang, et al.. (2017). Performance of multiple docking and refinement methods in the pose prediction D3R prospective Grand Challenge 2016. Journal of Computer-Aided Molecular Design. 32(1). 113–127. 6 indexed citations
6.
Gao, Ying‐Duo, Yuan Hu, Alejandro Crespo, et al.. (2017). Workflows and performances in the ranking prediction of 2016 D3R Grand Challenge 2: lessons learned from a collaborative effort. Journal of Computer-Aided Molecular Design. 32(1). 129–142. 7 indexed citations
7.
Patil, Renukadevi, Erzsébet Szabó, James I. Fells, et al.. (2015). Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA2 Receptor-Specific Nonlipid Agonist. Chemistry & Biology. 22(2). 206–216. 34 indexed citations
8.
Patil, Renukadevi, James I. Fells, Erzsébet Szabó, et al.. (2014). Design and Synthesis of Sulfamoyl Benzoic Acid Analogues with Subnanomolar Agonist Activity Specific to the LPA2 Receptor. Journal of Medicinal Chemistry. 57(16). 7136–7140. 13 indexed citations
9.
Morales‐Lázaro, Sara L., Itzel Llorente, Ricardo González‐Ramírez, et al.. (2014). Structural Determinants of the Transient Receptor Potential 1 (TRPV1) Channel Activation by Phospholipid Analogs. Journal of Biological Chemistry. 289(35). 24079–24090. 32 indexed citations
10.
Fells, James I., Sue Çhin Lee, Yuko Fujiwara, et al.. (2013). Hits of a High-Throughput Screen Identify the Hydrophobic Pocket of Autotaxin/Lysophospholipase D As an Inhibitory Surface. Molecular Pharmacology. 84(3). 415–424. 29 indexed citations
11.
Fells, James I., Sue-Chin Lee, Jianxiong Liu, et al.. (2012). Virtual Screening for LPA2-Specific Agonists Identifies a Nonlipid Compound with Antiapoptotic Actions. Molecular Pharmacology. 82(6). 1162–1173. 52 indexed citations
12.
Gotoh, Mari, Yuko Fujiwara, Junming Yue, et al.. (2012). Controlling cancer through the autotaxin–lysophosphatidic acid receptor axis. Biochemical Society Transactions. 40(1). 31–36. 77 indexed citations
13.
Lee, Sue-Chin, James I. Fells, Jianxiong Liu, et al.. (2012). Mitigation of radiation injury by selective stimulation of the LPA2 receptor. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(1). 117–125. 30 indexed citations
14.
Patil, Renukadevi, Jianxiong Liu, Yaohong Wang, et al.. (2011). Benzyl and Naphthalene Methylphosphonic Acid Inhibitors of Autotaxin with Anti‐invasive and Anti‐metastatic Activity. ChemMedChem. 6(5). 922–935. 51 indexed citations
15.
Fells, James I., Ryoko Tsukahara, Jianxiong Liu, Gábor Tigyi, & Abby L. Parrill. (2010). 2D binary QSAR modeling of LPA3 receptor antagonism. Journal of Molecular Graphics and Modelling. 28(8). 828–833. 6 indexed citations
16.
Zhang, Honglu, Xiaoyu Xu, Joanna Gajewiak, et al.. (2009). Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo. Cancer Research. 69(13). 5441–5449. 132 indexed citations
17.
Fells, James I., Ryoko Tsukahara, Jianxiong Liu, Gábor Tigyi, & Abby L. Parrill. (2009). Structure-based drug design identifies novel LPA3 antagonists. Bioorganic & Medicinal Chemistry. 17(21). 7457–7464. 27 indexed citations
18.
Fells, James I., Ryoko Tsukahara, Yuko Fujiwara, et al.. (2008). Identification of non-lipid LPA3 antagonists by virtual screening. Bioorganic & Medicinal Chemistry. 16(11). 6207–6217. 30 indexed citations
19.
Fells, James I., et al.. (2007). Molecular recognition in the sphingosine 1-phosphate receptor family. Journal of Molecular Graphics and Modelling. 26(8). 1189–1201. 23 indexed citations
20.
Holdsworth, Gill, Daniel A. Osborne, James I. Fells, et al.. (2004). A single amino acid determines preference between phospholipids and reveals length restriction for activation ofthe S1P4 receptor. BMC Biochemistry. 5(1). 12–12. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shi-Hao Tan Breakdown of academic impact, for papers by Charles A. Berdan Breakdown of academic impact, for papers by Rachel Kama Breakdown of academic impact, for papers by Pasquale Zizza Breakdown of academic impact, for papers by Henning Gram Hansen Breakdown of academic impact, for papers by Beth A. Strifler Breakdown of academic impact, for papers by Junya Hasegawa Breakdown of academic impact, for papers by Taichi Kumanomidou Breakdown of academic impact, for papers by Pornpun Aramsangtienchai Breakdown of academic impact, for papers by Haixia Zou
Rankless by CCL
2026